Fluonic

Fluonic, founded as a privately held medical device company, is dedicated to enhancing the safety and efficiency of infusion drug delivery. The company's core mission is to improve patient safety and compliance while boosting medical staff productivity and reducing healthcare costs. Fluonic offers a range of products and services, including advanced infusion pumps, urine monitoring systems, and artificial pancreas solutions. Their innovative MEMS flow sensor technology, which operates on a time-of-flight principle using electrolysis, sets a new standard of care in the medical industry.

Notable affiliated individuals and investors include experts in medical technology and venture capital firms specializing in healthcare innovations. Fluonic has achieved significant milestones, such as developing breakthrough MEMS flow sensor technology that enhances the precision and reliability of infusion devices. The company's impact is evident in its contribution to safer, more efficient drug delivery systems, which benefit both patients and healthcare providers by improving outcomes and reducing operational costs.